Menu
Your Cart
FREE SHIPPING ON ALL ORDERS OVER $85 on all orders Shop now 

SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss

SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
New
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
SLU-PP-332 Powder 3RD Party Tested CAS 303760-60-3 for Regulating Metabolism Weight Loss
  • Stock: In Stock
  • Model: SLU-PP-332
  • SKU: 303760-60-3
190 samples sold
Product Views: 62
$42.86
Ex Tax: $42.86

Available Options

SLU-PP-332 is an investigational compound that is a selective agonist of the REV-ERBα receptor, which plays a role in the regulation of circadian rhythms, metabolism, and inflammatory processes. It is gaining attention in experimental models related to energy homeostasis, inflammation reduction, and neurodegeneration.SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes. The compound exhibits properties related to enhanced mitochondrial biogenesis and oxidative phosphorylation in cellular models. 

SLU-PP-332 achieves fat loss and blood glucose regulation by promoting fat oxidation and improving insulin sensitivity; it improves non-alcoholic fatty liver disease (NAFLD), reducing liver fat content; provides metabolic support for individuals who cannot exercise, maintaining muscle mass and function; reduces muscle loss during the fat loss process; and has broad prospects in the areas of fat loss, endurance enhancement, and metabolic improvement.

In laboratory studies, SLU-PP-332 is associated with research in areas such as:

modulation of circadian rhythm and sleep cycles,

reduction of inflammatory markers and neuroinflammation,

improving metabolic balance and glucose tolerance,

adjustment of lipid profile and cholesterol levels,

potential impact on neurodegenerative diseases.


Write a review

Please login or register to review